Dr. Bieniarz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
502 Elm St NE
Albuquerque, NM 87102Phone+1 505-841-1000Fax+1 505-843-2592
Education & Training
- Baylor College of MedicineFellowship, Cardiovascular Disease, 2005 - 2008
- Emory University School of MedicineResidency, Internal Medicine, 2002 - 2005
- Baylor College of MedicineClass of 1997
Certifications & Licensure
- NM State Medical License 2009 - 2027
- TX State Medical License 2005 - 2009
- GA State Medical License 2004 - 2005
- LA State Medical License 1999 - 2002
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 7 citationsBridge to transplantation with the TandemHeart: bending the indications in a chronic aortic dissection patient with postcardiotomy shock.Stephane Reverdin, Igor D. Gregoric, Biswajit Kar, Pranav Loyalka, Mark C. Bieniarz
Texas Heart Institute Journal. 2008-01-01 - 32 citationsPercutaneous ventricular assist device support in a patient with a postinfarction ventricular septal defect.Igor D. Gregoric, Mark C. Bieniarz, Harvinder Arora, O.H. Frazier, Biswajit Kar
Texas Heart Institute Journal. 2008-01-01 - 126 citationsVenous thromboembolism: Annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack ratesCharles E. Mahan, Matthew E. Borrego, Alex L. Woersching, Robert Federici, Ross Downey
Thrombosis and Haemostasis. 2012-06-28
Press Mentions
- Seek Emergency Care if Experiencing Symptoms of Heart Attack, StrokeOctober 6th, 2020
- First Patient Enrolled in Abiomed’s RECOVER IV Randomized Controlled Trial of Impella as a Therapy for AMI Cardiogenic ShockNovember 30th, 2023
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: